Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer

被引:85
|
作者
Marks, John H. [1 ]
Myers, Elizabeth A. [1 ]
Zeger, Erik L. [2 ]
Denittis, Albert S. [3 ]
Gummadi, Mounica [1 ]
Marks, Gerald J. [1 ]
机构
[1] Lankenau Inst Med Res, Marks Colorectal Surg Associates, Lankenau Med Ctr, Med Sci Bldg,Suite 375,100 East Lancaster Ave, Wynnewood, PA 19096 USA
[2] Lankenau Inst Med Res, Sect Med Oncol, Lankenau Med Ctr, 100 East Lancaster Ave, Wynnewood, PA 19096 USA
[3] Lankenau Inst Med Res, Sect Radiat Oncol, Lankenau Med Ctr, 100 East Lancaster Ave, Wynnewood, PA 19096 USA
关键词
Rectal cancer; Transanal TME (taTME); TATA; APR; Sphincter preservation; Laparoscopic rectal cancer; TME; NOTES; MINIMALLY INVASIVE SURGERY; LAPAROSCOPIC-ASSISTED RESECTION; DISTAL; 3; CM; CIRCUMFERENTIAL MARGIN; SPHINCTER PRESERVATION; PATHOLOGICAL OUTCOMES; LOCAL RECURRENCE; CLASICC TRIAL; OPEN-LABEL; PLANE;
D O I
10.1007/s00464-017-5597-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
The challenge of performing a good total mesorectal excision (TME) dissection, particularly in the distal 1/3 of the rectum, has spurred interest in new techniques. Robotic surgery is advocated by some, and more recently, a "new" approach, the transanal total mesorectal excision, has been popularized to address this problem. While great interest in this technique exists, little long-term outcome data are available. We have been utilizing a transanal abdominal transanal approach to TME in order to facilitate the distal dissection, and here, we provide our long-term outcomes using this approach in the management of rectal cancer. From a prospectively maintained rectal cancer database, we identified 373 consecutive rectal cancers treated with sphincter preservation surgery through a combined transanal and abdominal approach to TME. Perioperative, pathological, and oncologic outcomes were analyzed. Three hundred and seventy-three patients with rectal cancer underwent a transanally initiated TME with mean follow-up of 5.5 years. 91% of cancers were in the distal rectum. 68.9% were men and 53.2% of cancers were tethered or fixed on presentation. 97.7% received neoadjuvant radiotherapy (mean 5405 cGy, 5-fluorouracil based); average time from completion of neoadjuvant therapy to surgery was 11 weeks. 180 and 193 patients underwent completion of their operation through open and laparoscopic abdominal approaches. 96% of TME specimens were complete/near complete, 94% had a negative circumferential resection margin, and 98.6% had a negative distal margin. Perioperative morbidity and mortality rates were 13.4 and 0.3%. Overall local recurrence (LR), DM, and Kaplan-Meier 5-year actuarial survival were 7.4, 19.5, and 90%, respectively. This is the first report of long-term data using a transanal approach to TME supporting this approach for rectal cancer. Our data with 5-year follow-up show that adequate distal and circumferential margins with very good-quality TME specimens, and a low risk for LR with excellent overall survival can be achieved using this technique. Our long-term results support the promising reports of early experiences in the literature.
引用
收藏
页码:5248 / 5257
页数:10
相关论文
共 50 条
  • [1] Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer
    John H Marks
    Elizabeth A. Myers
    Erik L. Zeger
    Albert S. Denittis
    Mounica Gummadi
    Gerald J. Marks
    Surgical Endoscopy, 2017, 31 : 5248 - 5257
  • [2] LONG-TERM OUTCOMES OF TRANSANAL TOTAL MESORECTAL EXCISION FOR RECTAL CANCER
    Labalde Martinez, M.
    Vivas Lopez, A.
    Ocana Jimenez, J.
    Garcia Villar, O.
    Nevado Garcia, C.
    Narvaez Chavez, C.
    Garcia Borda, F. J.
    Ferrero Herrero, E.
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [3] The need to focus on long-term outcomes after transanal total mesorectal excision for rectal cancer
    Angulo-Cruzado, Michelle Antonella
    Luna-Abanto, Jorge
    COLORECTAL DISEASE, 2022, 24 (03) : 329 - 330
  • [4] Long-term outcomes of transanal total mesorectal excision for rectal cancer: what could we do to improve them?
    Labalde Martinez, Maria
    Nevado Garcia, Cristina
    Garcia Borda, Francisco J.
    Vivas Lopez, Alfredo
    Garcia Villar, Oscar
    Rubio Gonzalez, Eduardo
    Pelaez Torres, Pablo
    Ferrero Herrero, Eduardo
    MINERVA SURGERY, 2022, 77 (06): : 564 - 572
  • [5] Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision
    Larach, Jose Tomas
    Rajkomar, Amrish K. S.
    Smart, Philip J.
    McCormick, Jacob J.
    Heriot, Alexander G.
    Warrier, Satish K.
    COLORECTAL DISEASE, 2021, 23 (04) : 823 - 833
  • [6] Short-term Outcomes of Transanal Total Mesorectal Excision for Low Rectal Cancer
    Troller, Rebekka
    Adamina, Michel
    Grieder, Felix
    Gelpke, Hans
    Breitenstein, Stefan
    SWISS MEDICAL WEEKLY, 2015, 145 : S6 - S6
  • [7] Transanal total mesorectal excision for rectal cancer
    Hasegawa, Suguru
    Takahashi, Ryo
    Hida, Koya
    Kawada, Kenji
    Sakai, Yoshiharu
    SURGERY TODAY, 2016, 46 (06) : 641 - 653
  • [8] Transanal total mesorectal excision for rectal cancer
    Suguru Hasegawa
    Ryo Takahashi
    Koya Hida
    Kenji Kawada
    Yoshiharu Sakai
    Surgery Today, 2016, 46 : 641 - 653
  • [9] Long-term oncological results after transanal total mesorectal excision for rectal carcinoma
    Hol, Jeroen C.
    van Oostendorp, Stefan E.
    Tuynman, Jurriaan B.
    Sietses, Colin
    TECHNIQUES IN COLOPROCTOLOGY, 2019, 23 (09) : 903 - 911
  • [10] Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
    Maykel, Justin A.
    Hahn, Sue J.
    Beauharnais, Catherine C.
    Meyer, David C.
    Hill, Susanna S.
    Sturrock, Paul R.
    Davids, Jennifer S.
    Alavi, Karim
    DISEASES OF THE COLON & RECTUM, 2022, 65 (06) : 827 - 836